Pages that link to "Item:Q4665957"
From MaRDI portal
The following pages link to A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials (Q4665957):
Displayed 11 items.
- Dose-Finding Based on Efficacy-Toxicity Trade-Offs (Q70261) (← links)
- Design efficiency in dose finding studies (Q956828) (← links)
- Simulation-based sequential Bayesian design (Q997303) (← links)
- Optimal designs and limiting optimal designs for a trinomial response (Q1888873) (← links)
- Adaptive designs for selecting drug combinations based on efficacy-toxicity response (Q2475724) (← links)
- Adaptive designs for dose-finding based on efficacy-toxicity response (Q2492921) (← links)
- Bayesian Dose-Finding in Phase I/II Clinical Trials Using Toxicity and Efficacy Odds Ratios (Q3436524) (← links)
- Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design (Q4796210) (← links)
- Optimal sampling for repeated binary measurements (Q4818488) (← links)
- Up-and-Down Designs for Selecting the Dose with Maximum Success Probability (Q5458029) (← links)
- Determining a Maximum‐Tolerated Schedule of a Cytotoxic Agent (Q5714615) (← links)